Iron entry in neurons and astrocytes: A link with synaptic activity

Frontiers in Molecular Neuroscience

Volumn 8, Issue June, 2015, Pages

  Codazzi, Franca ^a,b   Pelizzoni, Ilaria ^b   Zacchetti, Daniele ^b   Grohovaz, Fabio ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Astrocytes; Iron; Neurons; Oxidative stress; Synapses

Indexed keywords

FERROUS ION; IRON BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NON TRANSFERRIN BOUND IRON; REACTIVE OXYGEN METABOLITE; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BRAIN CORTEX; CALCIUM TRANSPORT; CEREBROSPINAL FLUID; GLUTAMATERGIC SYNAPSE; HIPPOCAMPUS; IRON CHELATION; IRON TRANSPORT; LONG TERM POTENTIATION; NERVE DEGENERATION; NEUROMODULATION; NEUROPROTECTION; OLIGODENDROGLIA; OXIDATIVE STRESS; PARKINSON DISEASE; SYNAPTIC TRANSMISSION;

EID: 84935890520     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2015.00018     Document Type: Article

References (53)

1. Altamura, S., and Muckenthaler, M. U. (2009). Iron toxicity in diseases of aging: Alzheimer’s disease, Parkinson’s disease and atherosclerosis. J. Alzheimers Dis. 16, 879-895. doi: 10.3233/JAD-2009-1010
2. Bishop, G. M., Dang, T. N., Dringen, R., and Robinson, S. R. (2011). Accumulation of non-transferrin-bound iron by neurons, astrocytes and microglia. Neurotox. Res. 19, 443-451. doi: 10.1007/s12640-010-9195-x
3. Bradbury, M. W. (1997). Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69, 443-454. doi: 10.1046/j.1471-4159.1997.69020443.x
4. Breuer, W., Hershko, C., and Cabantchik, Z. I. (2000). The importance of non­transferrin bound iron in disorders of iron metabolism. Transfus. Sci. 23, 185-192. doi: 10.1016/s0955-3886(00)00087-4
5. Brissot, P., Ropert, M., Le Lan, C., and Loreal, O. (2012). Non-transferrin bound iron: A keyrole in iron overload and iron toxicity. Biochim. Biophys. Acta 1820, 403-410. doi: 10.1016/j.bbagen.2011.07.014
6. Cheah, J. H., Kim, S. F., Hester, L. D., Clancy, K. W., Patterson, S. E. 3rd, Papadopoulos, V., et al. (2006). NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440. doi: 10.1016/j.neuron.2006.07.011
7. Chen, Y., Khan, R. S., Cwanger, A., Song, Y., Steenstra, C., Bang, S., et al. (2013). Dexras1, a small GTPase, is required for glutamate-NMDA neurotoxicity. J. Neurosci. 33, 3582-3587. doi: 10.1523/JNEUROSCI.1497-12.2013
8. Crichton, R. R., and Charloteaux-Wauters, M. (1987). Iron transport and storage. Eur. J. Biochem. 164, 485-506. doi: 10.1111/j.1432-1033.1987.tb11155.x
9. Crichton, R. R., Dexter, D. T., and Ward, R. J. (2011). Brain iron metabolism and its perturbation in neurological diseases. J. Neural Transm. 118, 301-314. doi: 10.1007/s00702-010-0470-z
10. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., et al. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072. doi: 10.1016/j.cell.2012.03.042
11. Du, F., Qian, Z. M., Zhu, L., Wu, X. M., Yung, W. H., Tsim, T. Y., et al. (2009). L-DOPA neurotoxicity is mediated by up-regulation ofDMT1-IRE expression. PLoS One 4:e4593. doi: 10.1371/journal.pone.0004593
12. Gaasch, J. A., Geldenhuys, W. J., Lockman, P. R., Allen, D. D., and Van der Schyf, C. J. (2007). Voltage-gated calcium channels provide an alternate route for iron uptake in neuronal cell cultures. Neurochem. Res. 32, 1686-1693. doi: 10.1007/s11064-007-9313-1
13. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., et al. (1997). Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488. doi: 10.1038/41343
14. Haeger, P., Alvarez, A., Leal, N., Adasme, T., Nuńez, M. T., and Hidalgo, C. (2010). Increased hippocampal expression of the divalent metal transporter 1 (DMT1) mRNA variants 1B and +IRE and DMT1 protein after NMDA- receptor stimulation or spatial memory training. Neurotox. Res. 17, 238-247. doi: 10.1007/s12640-009-9096-z
15. Halliwell, B. (2006). Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 97, 1634-1658. doi: 10.1111/j.1471-4159.2006.03907.x
16. Hentze, M. W., Muckenthaler, M. U., Galy, B., and Camaschella, C. (2010). Two to tango: regulation of Mammalian iron metabolism. Cell 142, 24-38. doi: 10.1016/j.cell.2010.06.028
17. Hershko, C., Graham, G., Bates, G. W., and Rachmilewitz, E. A. (1978). Non­specific serum iron in thalassaemia: An abnormal serum iron fraction of potentialtoxicity. Br. J. Haematol. 40,255-263. doi: 10.1111/j.1365-2141.1978.tb03662.x
18. Hider, R. C. (2002). Nature of nontransferrin-bound iron. Eur. J. Clin. Invest.32(Suppl. 1), 50-54. doi: 10.1046/j.1365-2362.2002.0320s1050.x
19. Hozumi, I., Hasegawa, T., Honda, A., Ozawa, K., Hayashi, Y., Hashimoto, K., et al. (2011). Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95-99. doi: 10.1016/j.jns.2011.01.003
20. Huang, E., Ong, W. Y., Go, M. L., and Connor, J. R. (2006). Upregulation of iron regulatory proteins and divalent metal transporter-1 isoforms in the rat hippocampus after kainate induced neuronal injury. Exp. Brain Res. 170, 376-386. doi: 10.1007/s00221-005-0220-x
21. Hubert, N., and Hentze, M. W. (2002). Previously uncharacterized isoforms of divalent metal transporter (DMT)-1: Implications for regulation and cellular function. Proc. Natl. Acad. Sci. USA 99, 12345-12350. doi: 10.1073/pnas.192423399
22. Janssen, M. C., and Swinkels, D. W. (2009). Hereditary haemochromatosis. Best Pract. Res. Clin. Gastroenterol. 23, 171-183. doi: 10.1016/j.bpg.2009.02.004
23. Jeong, S. Y., and David, S. (2006). Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice. J. Neurosci. 26, 9810-9819. doi: 10.1523/jneurosci.2922-06.2006
24. Ke, Y., Ho, K., Du, J., Zhu, L., Xu, Y., Wang, Q., et al. (2006). Role of soluble ceruloplasmin in iron uptake by midbrain and hippocampus neurons. J. Cell Biochem. 98, 912-919. doi: 10.1002/jcb.20740
25. Lane, D. J., Robinson, S. R., Czerwinska, H., Bishop, G. M., and Lawen, A. (2010). Two routes of iron accumulation in astrocytes: ascorbate-dependent ferrous iron uptake via the divalent metal transporter (DMT1) plus an independent route for ferric iron. Biochem. J. 432, 123-132. doi: 10.1042/BJ20101317
26. Lopin, K. V., Gray, I. P., Obejero-Paz, C. A., Thevenod, F., and Jones, S. W. (2012). Fe2+ block and permeation of CaV3.1 (a1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe2+ influx. Mol. Pharmacol. 82, 1194-1204. doi: 10.1124/mol.112.080184
27. Macco, R., Pelizzoni, I., Consonni, A., Vitali, I., Giacalone, G., Martinelli Boneschi, F., et al. (2013). Astrocytes acquire resistance to iron-dependent oxidative stress upon proinflammatory activation. J. Neuroinflammation 10:130. doi: 10.1186/1742-2094-10-130
28. Mackenzie, B., Takanaga, H., Hubert, N., Rolfs, A., and Hediger, M. A. (2007). Functional properties of multiple isoforms of human divalent metal-ion transporter 1 (DMT1). Biochem. J. 403, 59-69. doi: 10.1042/bj20061290
29. Mizuno, S., Mihara, T., Miyaoka, T., Inagaki, T., and Horiguchi, J. (2005). CSF iron, ferritin and transferrin levels in restless legs syndrome. J. Sleep Res. 14, 43-47. doi: 10.1111/j.1365-2869.2004.00403.x
30. Molina, J. A., Jimenez-Jimenez, F. J., Aguilar, M. V., Meseguer, I., Mateos- Vega, C. J., Gonzâlez-Munoz, M. J., et al. (1998). Cerebrospinal fluid levels of transition metals in patients with Alzheimer’s disease. J. Neural Transm. 105, 479-488. doi: 10.1007/s007020050071
31. Moos, T., and Morgan, E. H. (1998). Evidence for low molecular weight, non­transferrin-bound iron in rat brain and cerebrospinal fluid. J. Neurosci. Res. 54, 486-494. doi: 10.1002/(sici)1097-4547(19981115)54:4<486::aid-jnr6>3.0.co;2-i
32. Moos, T., and Morgan, E. H. (2004). The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain. J. Neurochem. 88, 233-245. doi: 10.1046/j.1471-4159.2003.02142.x
33. Moos, T., Rosengren Nielsen, T., Skj0rringe, T., and Morgan, E. H. (2007). Iron trafficking inside the brain. J.Neurochem. 103, 1730-1740. doi: 10.1111/j.1471-4159.2007.04976.x
34. Muńoz, P., Humeres, A., Elgueta, C., Kirkwood, A., Hidalgo, C., and Nunez, M. T. (2011). Iron mediates N-methyl-D-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J. Biol. Chem. 286, 13382-13392. doi: 10.1074/jbc.m110.213785
35. Oudit, G. Y., Sun, H., Trivieri, M. G., Koch, S. E., Dawood, F., Ackerley, C., et al. (2003). L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat. Med. 9, 1187-1194. doi: 10.1038/nm920
36. Oudit, G. Y., Trivieri, M. G., Khaper, N., Liu, P. P., and Backx, P. H. (2006). Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy. J. Mol. Med. (Berl.) 84, 349-364. doi: 10.1007/s00109-005-0029-x
37. Palmer, M. J., Hull, C., Vigh, J., and von Gersdorff, H. (2003). Synaptic cleft acidification and modulation of short-term depression by exocytosed protons in retinal bipolar cells. J. Neurosci. 23, 11332-11341.
38. Pelizzoni, I., Macco, R., Morini, M. F., Zacchetti, D., Grohovaz, F., and Codazzi, F. (2011). Iron handling in hippocampal neurons: activity-dependent iron entry and mitochondria-mediated neurotoxicity. Aging Cell. 10, 172-183. doi: 10.1111/j.1474-9726.2010.00652.x
39. Pelizzoni, I., Macco, R., Zacchetti, D., Grohovaz, F., and Codazzi, F. (2008). Iron and calcium in the central nervous system: a close relationship in health and sickness. Biochem. Soc. Trans. 36, 1309-1312. doi: 10.1042/BST0361309
40. Pelizzoni, I., Zacchetti, D., Campanella, A., Grohovaz, F., and Codazzi, F. (2013). Iron uptake in quiescent and inflammation-activated astrocytes: a potentially neuroprotective control of iron burden. Biochim. Biophys. Acta 1832, 1326-1333. doi: 10.1016/j.bbadis.2013.04.007
41. Pelizzoni, I., Zacchetti, D., Smith, C. P., Grohovaz, F., and Codazzi, F. (2012). Expression of divalent metal transporter 1 in primary hippocampal neurons: reconsidering its role in non-transferrin-bound iron influx. J. Neurochem. 120, 269-278. doi: 10.1111/j.1471-4159.2011.07578.x
42. Rathore, K. I., Redensek, A., and David, S. (2012). Iron homeostasis in astrocytes and microglia is differentially regulated by TNF-alpha and TGF-^1. Glia 60, 738-750. doi: 10.1002/glia.22303
43. Russo, N., Edwards, M., Andrews, T., O'Brien, M., and Bhatia, K. P. (2004). Hereditary haemochromatosis is unlikely to cause movement disorders-a critical review. J. Neurol. 251, 849-852. doi: 10.1007/s00415-004-0445-9
44. Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., et al. (2008). Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of parkinson's disease. Proc. Natl. Acad. Sci. USA 105, 18578-18583. doi: 10.1073/pnas.0804373105
45. Saura, J. (2007). Microglial cells in astroglial cultures: a cautionary note. J. Neuroinflammation 4:26. doi: 10.1186/1742-2094-4-26
46. Semtner, M., Schaefer, M., Pinkenburg, O., and Plant, T. D. (2007). Potentiation of TRPC5 by protons. J. Biol. Chem. 282, 33868-33878. doi: 10.1074/jbc.m702577200
47. Tulpule, K., Robinson, S. R., Bishop, G. M., and Dringen, R. (2010). Uptake of ferrous iron by cultured rat astrocytes. J. Neurosci. Res. 88, 563-571. doi: 10.1002/jnr.22217
48. Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M., et al. (2013). Inflammation alters the expression of DMT1, FPN1 and hepcidin and causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541-549. doi: 10.1111/jnc.12244
49. Wang, C. Y., and Knutson, M. D. (2013). Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin- bound iron uptake in mice. Hepatology 58, 788-798. doi: 10.1002/hep.26401
50. Wang, D., Wang, L. H., Zhao, Y., Lu, Y. P., and Zhu, L. (2010). Hypoxia regulates the ferrous iron uptake and reactive oxygen species level via divalent metal transporter 1 (DMT1) Exon1B by hypoxia-inducible factor-1. IUBMB Life. 62, 629-636. doi: 10.1002/iub.363
51. Xiong, Z. G., Pignataro, G., Li, M., Chang, S. Y., and Simon, R. P. (2008). Acid- sensingion channels (ASICs) as pharmacological targets for neurodegenerative diseases. Curr. Opin. Pharmacol. 8,25-32. doi: 10.1016/j.coph.2007.09.001
52. Yanatori, I., Tabuchi, M., Kawai, Y., Yasui, Y., Akagi, R., and Kishi, F. (2010). Heme and non-heme iron transporters in non-polarized and polarized cells. BMC Cell Biol. 11:39. doi: 10.1186/1471-2121-11-39
53. Zarruk, J. G., Berard, J. L., Passos Dos Santos, R., Kroner, A., Lee, J., Arosio, P., et al. (2015). Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation. Neurobiol Dis. doi: 10.1016/j.nbd.2015.02.001 [Epub ahead of print].